• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在氨基酸水平上对人白细胞介素-6/人白细胞介素-6受体结合界面的分析:提出的相互作用机制。

Analysis of the human interleukin-6/human interleukin-6 receptor binding interface at the amino acid level: proposed mechanism of interaction.

作者信息

Kalai M, Montero-Julian F A, Grötzinger J, Fontaine V, Vandenbussche P, Deschuyteneer R, Wollmer A, Brailly H, Content J

机构信息

Institut Pasteur de Bruxelles, Département de Virologie, Belgium.

出版信息

Blood. 1997 Feb 15;89(4):1319-33.

PMID:9028955
Abstract

The interaction between interleukin-6 (IL-6) and IL-6 receptor (IL-6R) is the initial and most specific step in the IL-6 signaling pathway. Understanding its mechanism at the amino acid level is the basis for developing small IL-6-inhibiting molecules. We studied the human IL-6 (hIL-6)/hIL-6R binding interface by a combination of molecular modelling and site-directed mutagenesis. Our model suggests that the center of the interface between the two molecules consists of hydrophobic contacts predicted to account for most of the binding-free energy. These contacts can be regarded as a hydrophobic core shielded by hydrophilic residues that are also needed for recognition. Following this hypothesis, we altered in hIL-6 and hIL-6R residues predicted to reside in the contact region and to interact with each other. We studied the capacity of these mutants to form an IL-6/IL-6R complex and their ability to transduce the signal. This combined approach has led to the identification of certain residue-clusters in the binding interface and to a rational explanation of their specific interactions, suggesting therein a likely mechanism of complex formation. The results confirm the predictive model and strongly support our hypothesis. Comparison with other cytokines and their alpha-subunit receptors suggests that the structural location of certain binding sites are conserved.

摘要

白细胞介素-6(IL-6)与白细胞介素-6受体(IL-6R)之间的相互作用是IL-6信号通路的起始且最具特异性的步骤。在氨基酸水平上理解其机制是开发小型IL-6抑制分子的基础。我们通过分子建模和定点诱变相结合的方法研究了人IL-6(hIL-6)/hIL-6R的结合界面。我们的模型表明,两个分子之间界面的中心由疏水接触组成,预计这些疏水接触占结合自由能的大部分。这些接触可被视为一个疏水核心,被识别所需的亲水性残基所屏蔽。根据这一假设,我们改变了hIL-6和hIL-6R中预计位于接触区域且相互作用的残基。我们研究了这些突变体形成IL-6/IL-6R复合物的能力及其转导信号的能力。这种综合方法已导致在结合界面中鉴定出某些残基簇,并对它们的特异性相互作用作出了合理的解释,由此暗示了复合物形成的可能机制。结果证实了预测模型,并有力地支持了我们的假设。与其他细胞因子及其α亚基受体的比较表明,某些结合位点的结构位置是保守的。

相似文献

1
Analysis of the human interleukin-6/human interleukin-6 receptor binding interface at the amino acid level: proposed mechanism of interaction.在氨基酸水平上对人白细胞介素-6/人白细胞介素-6受体结合界面的分析:提出的相互作用机制。
Blood. 1997 Feb 15;89(4):1319-33.
2
Interleukin-6 (IL-6) antagonism by soluble IL-6 receptor alpha mutated in the predicted gp130-binding interface.在预测的gp130结合界面发生突变的可溶性白细胞介素-6受体α对白细胞介素-6(IL-6)的拮抗作用。
J Biol Chem. 1995 May 19;270(20):12242-9. doi: 10.1074/jbc.270.20.12242.
3
Molecular modeling-guided mutagenesis of the extracellular part of gp130 leads to the identification of contact sites in the interleukin-6 (IL-6).IL-6 receptor.gp130 complex.gp130胞外部分的分子建模引导诱变导致了白细胞介素-6(IL-6)、IL-6受体、gp130复合物中接触位点的鉴定。
J Biol Chem. 1997 Sep 19;272(38):23748-57. doi: 10.1074/jbc.272.38.23748.
4
Identification of single amino acid residues of human IL-6 involved in receptor binding and signal initiation.鉴定参与人白细胞介素-6受体结合和信号启动的单个氨基酸残基。
J Interferon Cytokine Res. 1996 Aug;16(8):569-76. doi: 10.1089/jir.1996.16.569.
5
Activation of the signal transducer glycoprotein 130 by both IL-6 and IL-11 requires two distinct binding epitopes.白细胞介素-6和白细胞介素-11对信号转导蛋白糖蛋白130的激活需要两个不同的结合表位。
J Immunol. 1999 Feb 1;162(3):1480-7.
6
Generation of interleukin-6 receptor antagonists by molecular-modeling guided mutagenesis of residues important for gp130 activation.通过对gp130激活重要残基进行分子模型引导诱变产生白细胞介素-6受体拮抗剂。
EMBO J. 1994 Mar 15;13(6):1357-67. doi: 10.1002/j.1460-2075.1994.tb06389.x.
7
Receptor engagement by viral interleukin-6 encoded by Kaposi sarcoma-associated herpesvirus.卡波西肉瘤相关疱疹病毒编码的病毒白细胞介素-6与受体的结合。
Blood. 2001 Nov 15;98(10):3042-9. doi: 10.1182/blood.v98.10.3042.
8
Identification of amino acid residues of gp130 signal transducer and gp80 alpha receptor subunit that are involved in ligand binding and signaling by human herpesvirus 8-encoded interleukin-6.鉴定由人疱疹病毒8编码的白细胞介素-6参与配体结合和信号传导的gp130信号转导子和gp80α受体亚基的氨基酸残基。
J Virol. 2002 Jun;76(11):5627-36. doi: 10.1128/jvi.76.11.5627-5636.2002.
9
Two distinct and independent sites on IL-6 trigger gp 130 dimer formation and signalling.白细胞介素-6上两个不同且独立的位点引发糖蛋白130二聚体的形成和信号传导。
EMBO J. 1995 May 1;14(9):1942-51. doi: 10.1002/j.1460-2075.1995.tb07186.x.
10
Participation of two Ser-Ser-Phe-Tyr repeats in interleukin-6 (IL-6)-binding sites of the human IL-6 receptor.两个丝氨酸-丝氨酸-苯丙氨酸-酪氨酸重复序列参与人白细胞介素-6(IL-6)受体的IL-6结合位点。
Eur J Biochem. 1996 Jun 15;238(3):714-23. doi: 10.1111/j.1432-1033.1996.0714w.x.

引用本文的文献

1
Next-Generation Protein Sequencing and individual ion mass spectrometry enable complementary analysis of interleukin-6.新一代蛋白质测序和单离子质谱能够对白介素-6进行互补分析。
bioRxiv. 2025 Feb 8:2025.02.07.637157. doi: 10.1101/2025.02.07.637157.
2
Whole-Body Physiologically Based Pharmacokinetic Modeling of GalNAc-Conjugated siRNAs.N-乙酰半乳糖胺缀合的小干扰RNA的全身生理药代动力学建模
Pharmaceutics. 2025 Jan 6;17(1):69. doi: 10.3390/pharmaceutics17010069.
3
Unveiling novel insights into human IL-6 - IL-6R interaction sites through 3D computer-guided docking and systematic site mutagenesis.
通过 3D 计算机引导对接和系统位点诱变揭示人类 IL-6-IL-6R 相互作用位点的新见解。
Sci Rep. 2024 Aug 7;14(1):18293. doi: 10.1038/s41598-024-69429-w.
4
Taming the cytokine storm: small molecule inhibitors targeting IL-6/IL-6α receptor.驯服细胞因子风暴:靶向白细胞介素-6/白细胞介素-6α受体的小分子抑制剂
Mol Divers. 2024 Dec;28(6):4151-4165. doi: 10.1007/s11030-023-10805-5. Epub 2024 Feb 17.
5
(Burm.f.) Iwarsson aerial parts aqueous extract mitigates cisplatin-induced nephrotoxicity via attenuation of inflammation, and DNA damage.(缅甸)伊瓦尔松地上部分水提取物通过减轻炎症和DNA损伤来减轻顺铂诱导的肾毒性。
Front Pharmacol. 2023 Aug 1;14:1221486. doi: 10.3389/fphar.2023.1221486. eCollection 2023.
6
Identification of small molecules as potential inhibitors of interleukin 6: a multi-computational investigation.鉴定小分子作为白细胞介素 6 的潜在抑制剂:多计算研究。
Mol Divers. 2023 Oct;27(5):2315-2330. doi: 10.1007/s11030-022-10558-7. Epub 2022 Nov 1.
7
Structure-based 3D-Pharmacophore modeling to discover novel interleukin 6 inhibitors: An in silico screening, molecular dynamics simulations and binding free energy calculations.基于结构的三维药效团模型发现新型白细胞介素 6 抑制剂:计算机筛选、分子动力学模拟和结合自由能计算。
PLoS One. 2022 Apr 6;17(4):e0266632. doi: 10.1371/journal.pone.0266632. eCollection 2022.
8
A potential peptide derived from cytokine receptors can bind proinflammatory cytokines as a therapeutic strategy for anti-inflammation.一种潜在的细胞因子受体衍生肽可以作为一种抗炎治疗策略与促炎细胞因子结合。
Sci Rep. 2019 Feb 19;9(1):2317. doi: 10.1038/s41598-018-36492-z.
9
Interleukin (IL)-6 Inhibits IL-27- and IL-30-Mediated Inflammatory Responses in Human Monocytes.白细胞介素 (IL)-6 抑制人单核细胞中白细胞介素 (IL)-27 和白细胞介素 (IL)-30 介导的炎症反应。
Front Immunol. 2018 Feb 15;9:256. doi: 10.3389/fimmu.2018.00256. eCollection 2018.
10
Structural Mimicry of Receptor Interaction by Antagonistic Interleukin-6 (IL-6) Antibodies.拮抗性白细胞介素-6(IL-6)抗体对受体相互作用的结构模拟
J Biol Chem. 2016 Jun 24;291(26):13846-54. doi: 10.1074/jbc.M115.695528. Epub 2016 Apr 27.